Market
BSE Prices delayed by 5 minutes... << Prices as on Apr 19, 2024 >>  ABB India  6291.2 [ -1.19% ] ACC  2406.8 [ -0.22% ] Ambuja Cements  609.45 [ -1.11% ] Asian Paints Ltd.  2808.45 [ -0.22% ] Axis Bank Ltd.  1029.5 [ 0.52% ] Bajaj Auto  8795.45 [ -2.47% ] Bank of Baroda  256.95 [ -0.85% ] Bharti Airtel  1288.9 [ 1.71% ] Bharat Heavy Ele  254.45 [ 0.51% ] Bharat Petroleum  585.9 [ -0.65% ] Britannia Ind.  4668.1 [ -0.57% ] Cipla  1345.35 [ -0.17% ] Coal India  435.25 [ -0.80% ] Colgate Palm.  2650.65 [ -0.58% ] Dabur India  504.35 [ 0.05% ] DLF Ltd.  855.85 [ -0.02% ] Dr. Reddy's Labs  5942.65 [ -0.28% ] GAIL (India)  202 [ -0.76% ] Grasim Inds.  2274.35 [ 2.10% ] HCL Technologies  1447.9 [ -1.35% ] HDFC  2729.95 [ -0.62% ] HDFC Bank  1531.3 [ 2.46% ] Hero MotoCorp  4215.15 [ -0.88% ] Hindustan Unilever L  2232.25 [ 0.78% ] Hindalco Indus.  614.5 [ 0.28% ] ICICI Bank  1066.4 [ 1.04% ] IDFC L  122.75 [ 0.61% ] Indian Hotels Co  596.65 [ 0.50% ] IndusInd Bank  1483.15 [ 0.62% ] Infosys L  1411.6 [ -0.63% ] ITC Ltd.  424.8 [ 1.40% ] Jindal St & Pwr  927.45 [ 2.44% ] Kotak Mahindra Bank  1793.2 [ 0.38% ] L&T  3519.25 [ -0.89% ] Lupin Ltd.  1547.05 [ -2.92% ] Mahi. & Mahi  2082.9 [ 2.90% ] Maruti Suzuki India  12710.65 [ 2.54% ] MTNL  34.95 [ -2.21% ] Nestle India  2437.1 [ -1.04% ] NIIT Ltd.  105.35 [ -0.80% ] NMDC Ltd.  235.65 [ 0.26% ] NTPC  350.9 [ -0.14% ] ONGC  275.15 [ 0.31% ] Punj. NationlBak  128.25 [ -1.00% ] Power Grid Corpo  281.7 [ 0.54% ] Reliance Inds.  2941.6 [ 0.46% ] SBI  750.8 [ 0.81% ] Vedanta  385.85 [ -0.78% ] Shipping Corpn.  209.25 [ -0.69% ] Sun Pharma.  1522.55 [ 0.36% ] Tata Chemicals  1103.35 [ -0.21% ] Tata Consumer Produc  1137.5 [ 0.29% ] Tata Motors Ltd.  963.2 [ -0.84% ] Tata Steel  162.1 [ 1.31% ] Tata Power Co.  428 [ -0.44% ] Tata Consultancy  3827.45 [ -0.93% ] Tech Mahindra  1193.75 [ 1.18% ] UltraTech Cement  9367.4 [ -0.21% ] United Spirits  1122.7 [ -2.46% ] Wipro  452.85 [ 1.92% ] Zee Entertainment En  142.85 [ -1.45% ] 
Beta Drugs Ltd. Auditor Report
Search Company 
You can view full text of the latest Auditor's Report for the company.
Market Cap. (Rs.) 1344.49 Cr. P/BV 10.94 Book Value (Rs.) 127.82
52 Week High/Low (Rs.) 1595/660 FV/ML 10/200 P/E(X) 43.77
Bookclosure 30/09/2023 EPS (Rs.) 31.95 Div Yield (%) 0.00
Year End :2023-03 

Members of Beta Drugs Limited

Report on the Standalone Financial Statements

We have audited the accompanying standalone Ind-AS financial statements of Beta Drugs Limited ('the Company'), which comprise the Balance Sheet as at March 31,2023, the Statement of Profit and Loss, including the statement of Other Comprehensive Income, the Cash Flow Statement and the Statement of Changes in Equity for the year then ended, and a summary of significant accounting policies and other explanatory information.

Management's Responsibility for the Financial Statements

The Company's Board of Directors is responsible for the matters stated in Section 134(5) of the Companies Act, 2013 ('the Act') with respect to the preparation of these standalone Ind-AS financial statements that give a true and fair view of the financial position, financial performance including other comprehensive income, cash flows and changes in equity of the Company in accordance with accounting principles generally accepted in India, including the Indian Accounting Standards (Ind-AS) specified under Section 133 of the Act., read with the Companies (Indian Accounting Standards) Rules, 2015, as amended. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial control that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the Ind-AS financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.

Auditor's Responsibility

Our responsibility is to express an opinion on these standalone Ind-AS financial statements based on our audit. We have taken into account the provisions of the Act, the accounting and auditing standards and matters which are required to be included in the audit report under the provisions of the Act and the Rules made there under. We conducted our audit of the standalone Ind-AS financial statements in accordance with the Standards on Auditing, issued by the Institute of Chartered Accountants of India, as specified under Section 143(10) of the Act. Those Standards require that we comply with ethical requirements and plan and perform the audit to obtain reasonable assurance about whether the financial statements are free from material misstatement.

An audit involves performing procedures to obtain audit evidence about the amounts and disclosures in the financial statements. The procedures selected depend on the auditor's judgment, including the assessment of the risks of material misstatement of the standalone Ind-AS financial statements, whether due to fraud or error. In making those risk assessments, the auditor considers internal financial control relevant to the Company's preparation of the standalone Ind-AS financial statements that give a true and fair view in order to design audit procedures that are appropriate in the circumstances. An audit also includes evaluating the appropriateness of accounting policies used and the reasonableness of the accounting estimates made by the Company's Directors, as well as evaluating the overall presentation of the standalone Ind-AS financial statements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our audit opinion on the standalone Ind AS financial statements.

Opinion

In our opinion and to the best of our information and according to the explanations given to us, the standalone Ind-AS financial statements give the information required by the Act in the manner so required and give a true and fair view inconformity with the accounting principles generally accepted in India, of the state of affairs of the Company as at March 31, 2023, its profit including other comprehensive income, its cash flows and the changes in equity for the year ended on that date.

Report on Other Legal and Regulatory Requirements

1. As required by the Companies (Auditor's report) Order, 2016 ('the Order') issued by the Central Government of India in terms of subsection (11) of Section 143 of the Act, we give in the Annexure 1 a statement on the matters specified in paragraphs 3 and 4 of the Order.

2. As required by Section 143 (3) of the Act, we report that:

a. We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purpose of our audit;

b. In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of those books;

c. The Balance Sheet, Statement of Profit and Loss including the Statement of Other Comprehensive Income, the Cash Flow Statement and Statement of Changes in Equity dealt with by this Report are in agreement with the books of account;

d. In our opinion, the aforesaid standalone Ind-AS financial statements comply with the Indian Accounting Standards specified under Section 133 of the Act, read with Companies (Indian Accounting Standards) Rules, 2015, as amended;

e. On the basis of written representations received from the directors as on March 31,2023, and taken on record by the Board of Directors, none of the Director is disqualified as on March 31, 2023, from being appointed as a director in terms of Section 164 (2) of the Act.

f. With respect to the adequacy of the internal financial controls over financial reporting of the Company and the operating effectiveness of such controls, refers to our separate Report in “Annexure B”;

g. With respect to the other matters to be included in the Auditor's Report in accordance with Rule 11 of the Companies (Audit and Auditors) Rules, 2020, in our opinion and to the best of our information and according to the explanations given to us:

i. The Company has disclosed the impact of pending litigations on its financial position in its financial statements.

ii. The Company did not have any long-term contracts including derivative contracts for which there were any material foreseeable losses;

iii. There has been no amounts available which is required to be transferred, to the Investor Education and Protection Fund by the Company;

For KALRA RAI & ASSOCIATES

Place:- Chandigarh

Date: 08/05/2023 Chartered Accountants

UDIN:23087438BGVHEH8160

Sd/-

(Lajpat Rai Kalra)

Partner M. No-087438 FRN: 008859N


KYC IS ONE TIME EXERCISE WHILE DEALING IN SECURITIES MARKETS - ONCE KYC IS DONE THROUGH A SEBI REGISTERED INTERMEDIARY (BROKER, DP, MUTUAL FUND ETC.), YOU NEED NOT UNDERGO THE SAME PROCESS AGAIN WHEN YOU APPROACH ANOTHER INTERMEDIARY. | PREVENT UNAUTHORISED TRANSACTIONS IN YOUR ACCOUNT --> UPDATE YOUR MOBILE NUMBERS/EMAIL IDS WITH YOUR STOCK BROKER/DEPOSITORY PARTICIPANT. RECEIVE INFORMATION/ALERT OF YOUR TRANSACTIONS DIRECTLY FROM EXCHANGE/NSDL ON YOUR MOBILE/EMAIL AT THE END OF THE DAY .......... ISSUED IN THE INTEREST OF INVESTORS
 
Disclaimer Clause | Privacy | Terms of Use | Rules and regulations | Feedback| IG Redressal Mechanism | Investor Charter | Client Bank Accounts
Right and Obligation, RDD, Guidance Note in Vernacular Language
Attention Investors : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
  "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
  "Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participants. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day.Issued in the interest of Investors."
Regd. Office: 76-77, Scindia House, 1st Floor, Janpath, Connaught Place, New Delhi – 110001
NSE CASH , NSE F&O,NSE CDS| BSE CASH ,BSE CDS |DP NSDL | MCX-SX SEBI NO: INZ000155732
KK Comtrade Pvt Ltd. : Member - MCXINDIA (Commodity Segment) , SEBI NO: INZ000034837
Mumbai Office: 52, Jolly Maker Chamber 2, Nariman Point, Mumbai - 400021, Tel: 022-45106700, Toll Free Number: 1800-103-6700

Compliance Officer: Mukesh Rustagi, Company Secretary, Tel: 011-46890000, Email: mukesh_rustagi80@hotmail.com
For grievances please e-mail at: kkslig@hotmail.com

Important Links : NSE | BSE | SEBI | NSDL | Speed-e | CDSL | SCORES | NSDL E-voting | CDSL E-voting
Copyrights @ 2014 © KK Securities Limited. All Right Reserved
Designed, developed and content provided by